Form D · Other Technology
BLOODHOUND, INC.
San Francisco, CA · CIK 0001543361
Offering snapshot reported Jan 23, 2013 · SEC filing
- Reported sold
- $3.88M Offering amount: $4.55M
- Investors reported
- 41 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 8, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 23, 2013 | Initial | $3,877,038 | No comparison | 41 | SEC filing |
| Feb 28, 2012 | Initial | $270,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190676
Source: Form D, filed Jan 23, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick Dugan | Director |
| Richard Fulton | Director, Executive |
| E. Anthony Krumeich Iv | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
712 Bryant Street, Unit 6
San Francisco, CA, 94107
San Francisco, CA, 94107